KPWHRI is taking part in a clinical trial of a nasal COVID-19 vaccine developed by Boost Biopharma Inc.
KPWHRI is recruiting Kaiser Permanente Washington members to take part.
New paper explores how health systems can improve opioid prescribing safety with patient-centered care.
KPWHRI volunteers help deliver free medical, dental, and optical care to attendees of the 4-day clinic.
Their work contributes to improved quality of care and better understanding of patients’ needs.
The NIH-sponsored trial will help inform decisions about vaccine approval for 12- to 17-year-olds.
Participant in KPWHRI trial receives world’s first-ever injection of investigational SchistoShield vaccination.
